Back

Kane Biotech to host Sept. 16 commercial update on revyve wound-care business

Verifying
  • Kane Biotech will host a virtual Commercial Update focused on its revyve wound-care business.
  • September 16, 2026, at 11:00 a.m. Eastern Time, the webcast will run approximately 60 minutes.
  • Kane’s portfolio includes three U.S. FDA 510(k)-cleared revyve products.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Kane Biotech to host Sept. 16 commercial update on revyve wound-care business - CoinPost Terminal